Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis

Summary

A randomized, double-blind, placebo-controlled multicenter, phase 3 study to evaluate the efficacy and safety of tezepelumab administered subcutaneously (SC) using an accessorized pre-filled syringe (APFS) versus placebo in adult and adolescent patients with eosinophilic esophagitis (EoE).

Timeline

Start

2022-11-10

Primary completion

2026-07-14

Completion

2027-03-23

Drugs

Indications